Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $30.6000 (6.66%) ($29.1460 - $30.9600) on Wed. Oct. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.83% (three month average) | RSI | 70 | Latest Price | $30.6000(6.66%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 2.8% a day on average for past five trading days. | Weekly Trend | TGTX advances 5.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(64%) ARKG(59%) ARKK(56%) IWO(56%) IBB(55%) | Factors Impacting TGTX price | TGTX will decline at least -1.915% in a week (0% probabilities). VIXM(-37%) VXX(-33%) UUP(-18%) DRIV(-6%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.915% (StdDev 3.83%) | Hourly BBV | 1.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $28.01(9.25%) | 10 Day Moving Average | $26.8(14.18%) | 20 Day Moving Average | $26.06(17.42%) | To recent high | 0% | To recent low | 65.5% | Market Cap | $3.875b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |